California Area OfficeMetabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes
July 16, 2026
Register online:
https://ihs-gov.zoomgov.com/meeting/register/wIhiz1oPRFWH685TKeezzA
Description:
This session will review current best practices for the identification, evaluation, and management of metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with type 2 diabetes, with a focus on early detection, risk stratification, and coordinated patient care.
Presenter:
Carol Greenlee, MD, MACP, Physician (Endocrinology)
